Amedisys(AMED) Stock Price Today | Quotes & News - Moomoo

English
中文繁體
中文简体

Dark
Light

Open Account

US Stock MarketDetailed Quotes

AMED Amedisys

Watchlist

92.030
-0.340-0.37%

Close Mar 10 16:00 ET

88.500
-3.530-3.84%

Post 20:01 ET

3.53BMarket Cap70.25P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Raymond James Maintains Amedisys(AMED.US) With Hold Rating
Moomoo News19:31 ET · Ratings
Amedisys Executive Makes a Bold Stock Sale!
TipRanksMar 6 21:07 ET
Amedisys Price Target Maintained With a $101.00/Share by Stephens & Co.
Dow JonesMar 4 08:58 ET · Ratings
Amedisys Analyst Ratings
BenzingaMar 4 08:47 ET · Ratings
Truist Financial Maintains Amedisys(AMED.US) With Hold Rating, Announces Target Price $101
Moomoo NewsMar 3 07:31 ET · Ratings
Amedisys | 10-K/A: Annual report (Amendment)
SECFeb 28 06:05 ET · Announcements

Comments

Michael_Lawrence

Sep 23, 2021 22:54

$Amedisys (AMED.US)$ divergency with good fundamental Also gap so it looks good and risk to rewards is acceptable

1

Jun 9, 2021 07:57

$Inhibikase Therapeutics (IKT.US)$
learn from
$Amedisys (AMED.US)$
$AMC Entertainment (AMC.US)$
$Fulcrum Therapeutics (FULC.US)$
JonesTrading analyst Soumit Roy initiates coverage on Inhibikase Therapeutics (NASDAQ:IKT) with a Buy rating and announces Price Target of $12.
$PharmaCyte Biotech (PMCB.US)$

2

Read more